| 12304908 |
Azabenzimidazoles and their use as AMPA receptor modulators |
Michael K. Ameriks, Cynthia G. B. Berry, Gang Chen, Fabrice Jourdan, Terry P. Lebold +6 more |
2025-05-20 |
|
| 11993601 |
Monoacylglycerol lipase modulators |
Michael K. Ameriks, Gang Chen, Chaofeng Huang, Brian Ngo Laforteza, Wei Zhang |
2024-05-28 |
$258,476,000 |
| 11891387 |
Monoacylglycerol lipase modulators |
Michael K. Ameriks, Brian Ngo Laforteza, Jamie M. Schiffer, Brice M. Stenne |
2024-02-06 |
$268,494,000 |
| 11820766 |
Monoacylglycerol lipase modulators |
Michael K. Ameriks, Gang Chen, Chaofeng Huang, Brian Ngo Laforteza, Emma Helen Southgate +1 more |
2023-11-21 |
$91,340,000 |
| 11597728 |
Monoacylglycerol lipase modulators |
Michael K. Ameriks, Gang Chen, Chaofeng Huang, Brian Ngo Laforteza, Wei Zhang |
2023-03-07 |
$225,152,000 |
| 11312712 |
Azabenzimidazoles and their use as AMPA receptor modulators |
Michael K. Ameriks, Cynthia G. B. Berry, Gang Chen, Bradley M. Savall, Devin M. Swanson +2 more |
2022-04-26 |
$374,634,000 |
| 10611730 |
Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators |
Michael K. Ameriks, Devin M. Swanson, Bradley M. Savall |
2020-04-07 |
$165,837,000 |
| 10604484 |
Indolone compounds and their use as AMPA receptor modulators |
Michael K. Ameriks, Bradley M. Savall, Devin M. Swanson, Jeannie M. Ziff, Brock T. Shireman |
2020-03-31 |
$129,196,000 |
| 10155769 |
Fused azaheterocyclic compounds and their use as AMPA receptor modulators |
Michael K. Ameriks, Brian Ngo Laforteza, Terry P. Lebold, Brad M. Savall, Brock T. Shireman |
2018-12-18 |
$201,471,000 |
| 10087185 |
Fused bicylic pyridine compounds and their use as AMPA receptor modulators |
Michael K. Ameriks, Márió Gyuris, Brian Ngo Laforteza, Terry P. Lebold, Stephen T. Meyer +4 more |
2018-10-02 |
$95,730,000 |
| 9303033 |
Pyrazolopyrimidines and related heterocycles as CK2 inhibitors |
Mustapha Haddach, Joe Tran, Fabrice Pierre, Collin Regan, Nicholas Brian Raffaele +1 more |
2016-04-05 |
|
| 8575177 |
Pyrazolopyrimidines and related heterocycles as CK2 inhibitors |
Mustapha Haddach, Joe Tran, Fabrice Pierre, Collin Regan, Nicholas Brian Raffaele +1 more |
2013-11-05 |
|
